These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 23604636)

  • 1. Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs.
    Shu Y; Haque F; Shu D; Li W; Zhu Z; Kotb M; Lyubchenko Y; Guo P
    RNA; 2013 Jun; 19(6):767-77. PubMed ID: 23604636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication of pRNA nanoparticles to deliver therapeutic RNAs and bioactive compounds into tumor cells.
    Shu Y; Shu D; Haque F; Guo P
    Nat Protoc; 2013 Sep; 8(9):1635-59. PubMed ID: 23928498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA nanotechnology: engineering, assembly and applications in detection, gene delivery and therapy.
    Guo P
    J Nanosci Nanotechnol; 2005 Dec; 5(12):1964-82. PubMed ID: 16430131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using Planar Phi29 pRNA Three-Way Junction to Control Size and Shape of RNA Nanoparticles for Biodistribution Profiling in Mice.
    Haque F; Xu C; Jasinski DL; Li H; Guo P
    Methods Mol Biol; 2017; 1632():359-380. PubMed ID: 28730451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy.
    Xu C; Haque F; Jasinski DL; Binzel DW; Shu D; Guo P
    Cancer Lett; 2018 Feb; 414():57-70. PubMed ID: 28987384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional assays for specific targeting and delivery of RNA nanoparticles to brain tumor.
    Lee TJ; Haque F; Vieweger M; Yoo JY; Kaur B; Guo P; Croce CM
    Methods Mol Biol; 2015; 1297():137-52. PubMed ID: 25896001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable RNA nanoparticles as potential new generation drugs for cancer therapy.
    Shu Y; Pi F; Sharma A; Rajabi M; Haque F; Shu D; Leggas M; Evers BM; Guo P
    Adv Drug Deliv Rev; 2014 Feb; 66():74-89. PubMed ID: 24270010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of Gastric Cancer by Systemic Injection of RNA Nanoparticles Carrying both Ligand and siRNA.
    Cui D; Zhang C; Liu B; Shu Y; Du T; Shu D; Wang K; Dai F; Liu Y; Li C; Pan F; Yang Y; Ni J; Li H; Brand-Saberi B; Guo P
    Sci Rep; 2015 Jul; 5():10726. PubMed ID: 26137913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology.
    Shu D; Li H; Shu Y; Xiong G; Carson WE; Haque F; Xu R; Guo P
    ACS Nano; 2015 Oct; 9(10):9731-40. PubMed ID: 26387848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using RNA nanoparticles with thermostable motifs and fluorogenic modules for real-time detection of RNA folding and turnover in prokaryotic and eukaryotic cells.
    Zhang H; Pi F; Shu D; Vieweger M; Guo P
    Methods Mol Biol; 2015; 1297():95-111. PubMed ID: 25895998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, conjugation, and labeling of multifunctional pRNA nanoparticles for specific delivery of siRNA, drugs, and other therapeutics to target cells.
    Guo P; Shu Y; Binzel D; Cinier M
    Methods Mol Biol; 2012; 928():197-219. PubMed ID: 22956144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer by RNA Nanotechnology.
    Binzel DW; Shu Y; Li H; Sun M; Zhang Q; Shu D; Guo B; Guo P
    Mol Ther; 2016 Aug; 24(7):1267-77. PubMed ID: 27125502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assembly of multifunctional phi29 pRNA nanoparticles for specific delivery of siRNA and other therapeutics to targeted cells.
    Shu Y; Cinier M; Shu D; Guo P
    Methods; 2011 Jun; 54(2):204-14. PubMed ID: 21320601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastable synergistic tetravalent RNA nanoparticles for targeting to cancers.
    Haque F; Shu D; Shu Y; Shlyakhtenko LS; Rychahou PG; Evers BM; Guo P
    Nano Today; 2012 Aug; 7(4):245-257. PubMed ID: 23024702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmable folding of fusion RNA in vivo and in vitro driven by pRNA 3WJ motif of phi29 DNA packaging motor.
    Shu D; Khisamutdinov EF; Zhang L; Guo P
    Nucleic Acids Res; 2014 Jan; 42(2):e10. PubMed ID: 24084081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controllable self-assembly of nanoparticles for specific delivery of multiple therapeutic molecules to cancer cells using RNA nanotechnology.
    Khaled A; Guo S; Li F; Guo P
    Nano Lett; 2005 Sep; 5(9):1797-808. PubMed ID: 16159227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods and assays for specific targeting and delivery of RNA nanoparticles to cancer metastases.
    Rychahou P; Shu Y; Haque F; Hu J; Guo P; Evers BM
    Methods Mol Biol; 2015; 1297():121-35. PubMed ID: 25896000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model.
    Lee TJ; Haque F; Shu D; Yoo JY; Li H; Yokel RA; Horbinski C; Kim TH; Kim SH; Kwon CH; Nakano I; Kaur B; Guo P; Croce CM
    Oncotarget; 2015 Jun; 6(17):14766-76. PubMed ID: 25885522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of chemically synthesized monomeric phi29 pRNA nanoparticles for systemic delivery.
    Abdelmawla S; Guo S; Zhang L; Pulukuri SM; Patankar P; Conley P; Trebley J; Guo P; Li QX
    Mol Ther; 2011 Jul; 19(7):1312-22. PubMed ID: 21468004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific delivery of therapeutic RNAs to cancer cells via the dimerization mechanism of phi29 motor pRNA.
    Guo S; Tschammer N; Mohammed S; Guo P
    Hum Gene Ther; 2005 Sep; 16(9):1097-109. PubMed ID: 16149908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.